These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18988756)

  • 1. Clinical performance of two highly sensitive cardiac troponin I assays.
    Venge P; James S; Jansson L; Lindahl B
    Clin Chem; 2009 Jan; 55(1):109-16. PubMed ID: 18988756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody configurations of cardiac troponin I assays may determine their clinical performance.
    James S; Flodin M; Johnston N; Lindahl B; Venge P
    Clin Chem; 2006 May; 52(5):832-7. PubMed ID: 16543388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay.
    van de Kerkhof D; Peters B; Scharnhorst V
    Ann Clin Biochem; 2008 May; 45(Pt 3):316-7. PubMed ID: 18482922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making.
    Eggers KM; Jaffe AS; Lind L; Venge P; Lindahl B
    Clin Chem; 2009 Jan; 55(1):85-92. PubMed ID: 18988758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.
    Venge P; Johnston N; Lagerqvist B; Wallentin L; Lindahl B;
    Clin Chem; 2003 Jun; 49(6 Pt 1):880-6. PubMed ID: 12765983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance with 3 Cardiac Troponin I and T Assays: Implications for the 99th Percentile Cutoff.
    Ungerer JP; Tate JR; Pretorius CJ
    Clin Chem; 2016 Aug; 62(8):1106-14. PubMed ID: 27335076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performance and clinical decision limit of a new release for cardiac troponin I assay.
    Moretti M; Pieretti B; Sisti D; Rocchi M; Gasperoni S
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):169-72. PubMed ID: 24711561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples.
    Storti S; Masotti S; Prontera C; Franzini M; Buzzi P; Casagranda I; Ciofini E; Zucchelli GC; Ndreu R; Passino C; Clerico A
    Clin Chim Acta; 2015 Dec; 451(Pt B):129-34. PubMed ID: 26391123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
    Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.
    Nikorowitsch J; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32143410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparability of Beckman Coulter Cardiac Troponin I Assays.
    Stanek CG; Lima J; Cao L
    Ann Clin Lab Sci; 2024 May; 54(3):408-412. PubMed ID: 39048176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the 99th percentile of a novel assay for high-sensitivity troponin I in a healthy blood donor population.
    Odsæter IH; Grenne B; Hov GG; Laugsand LE; Wiseth R; Mikkelsen G
    Clin Chem Lab Med; 2020 Aug; 58(9):1557-1563. PubMed ID: 32286238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay.
    Yang HS; Shemesh A; Li J; Xie T; Apple FS; Williams J; Zhao Z; Steel PAD
    Clin Biochem; 2021 Mar; 89():77-80. PubMed ID: 33296707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).
    Venge P; Lagerqvist Bo; Diderholm E; Lindahl B; Wallentin L
    Am J Cardiol; 2002 May; 89(9):1035-41. PubMed ID: 11988191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.